NOVO NORDISK LIMITED
Company Information
- Company Number
- 01118740
- Registered Address
- 3 City Place, Beehive Ring Road, Gatwick, West Sussex, United Kingdom, RH6 0PA
- Status
- Active
- Employee Count
- 427
- Turnover
- £494,246,000
- EBITDA
- £20,674,000
Additional Details
- Website
- https://pharmaguapa.com/
- Company Type
- Private limited Company
- Incorporated On
- 18 June 1973
- Nature of Business
- 46460 - Wholesale of pharmaceutical goods
- Industries
- Life Sciences And Medical Technology
- Region
- South East
Time to Pay
Payment Timeline
Payment Features
Payment Score History
Performance Reports History
| Reporting Period | Filing Date | Average Time to Pay (days) | Paid within 30 days | Paid 31-60 days | Paid after 60 days | Not Paid within Terms |
|---|---|---|---|---|---|---|
| 01 Jan 2024 - 30 Jun 2024 | 24 Jul 2024 | 32 | 64% | 28% | 8% | 14% |
| 01 Jul 2023 - 31 Dec 2023 | 22 Jan 2024 | 27 | 64% | 31% | 5% | 26% |
| 01 Jan 2023 - 30 Jun 2023 | 26 Jul 2023 | 28 | 63% | 30% | 7% | 25% |
| 01 Jul 2022 - 31 Dec 2022 | 25 Jan 2023 | 23 | 72% | 25% | 3% | 16% |
| 01 Jan 2021 - 30 Jun 2021 | 29 Jul 2021 | 27 | 65% | 33% | 2% | 16% |
| 01 Jan 2020 - 30 Jun 2020 | 29 Jul 2020 | 28 | 72% | 27% | 1% | 23% |
| 01 Jul 2018 - 31 Dec 2018 | 29 Jan 2019 | 28 | 67% | 30% | 3% | 24% |
| 01 Jan 2018 - 30 Jun 2018 | 27 Jul 2018 | 27 | 63% | 35% | 2% | 33% |
Payment Time Trends
Payment Distribution Trends
Invoice Payment Practices
This information is as reported by the business, and responses are in their own words.
Payment Terms
Standard payment terms
Standard terms range from immediate payment on receipt of invoices to 90 days on receipt of invoices.
Were there any changes to the standard payment terms in the reporting period?
No information available
Any other information about payment terms
N/A
Maximum contractual payment period agreed
90
Dispute Resolution Process
Suppliers can get in touch with Novo Nordisk Limited's Accounts Payable department for any invoice or payment queries via email. Disputes are managed directly with the supplier and resolved items are reprocessed. Novo Nordisk Limited is supported by a Global Business Service Centre Accounts Payable team who support suppliers with their queries.
Other Payment Information
Has this business signed up to a code of conduct or standards on payment practices?
For example, signatories to The Prompt Payment Code must commit to paying 95% of their invoices within 60 days.
❌
Does this business offer e-invoicing in relation to qualifying contracts?
This is where suppliers can electronically submit and track invoices. It's not just allowing suppliers to email them an invoice.
❌
Does this business offer supply chain finance?
This is where a supplier who has submitted an invoice can be paid by a third-party finance provider earlier than the agreed payment date. The business would then pay the finance provider the invoiced sum.
❌
Under its payment practices and policies, can this business deduct sums from payments under qualifying contracts as a charge for remaining on a supplier list?
❌
During the reporting period, did the business deduct sums from payments as a charge for remaining on a supplier list?
No information available
Company Summary
NOVO NORDISK LIMITED is a multinational pharmaceutical company that specializes in diabetes care and other chronic diseases. The company was founded in 1923 in Denmark and has since expanded its operations to more than 170 countries, including the United Kingdom.
The company's main focus is on developing innovative treatments and solutions for people living with diabetes. They offer a wide range of products, including insulin, oral anti-diabetic drugs, and devices for blood glucose monitoring. They also provide educational resources and support programs for patients and healthcare professionals.
NOVO NORDISK LIMITED is committed to sustainability and has implemented various initiatives to reduce their environmental impact. This includes achieving zero carbon emissions at their production sites and using sustainable packaging for their products. They also have a goal to be 100% renewable energy powered by 2020.
The company's key people include Lars Fruergaard Jørgensen, the President and CEO, and Mads Krogsgaard Thomsen, the Chief Science Officer. They are supported by a team of dedicated professionals who strive to make a positive impact on people's lives.
For more information on NOVO NORDISK LIMITED's products and services, you can visit their website at www.novonordisk.co.uk. Their registered office address is at 3 City Place, Beehive Ring Road, Gatwick, West Sussex, RH6 0PA, United Kingdom.
